Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
APRI--erectile dysfuntion approval news out-not moved yet--g/l--eom
APRI--erectile dysfuntion approval news out-not moved yet--g/l--eom
APRI--big news just out-pricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream - Vitaros(R) in Belgium
Vitaros(R) Remains on Track for Launch in 2014
SAN DIEGO, Jan. 23, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (" Apricus" or the "Company") (Nasdaq:APRI) (www.apricusbio.com), today announced that Belgium's Ministry of Social Affairs, Public Health and Environment has granted national phase approval to Vitaros(R) , indicated for the treatment of patients with erectile dysfunction ("ED"). The Company has now received a total of eight national phase approvals for Vitaros(R) , including Belgium, France, Germany, Ireland, Italy, the Netherlands, Sweden and the United Kingdom ("UK") following its broad approval by European health authorities in June 2013. Apricus has an exclusive commercialization partnership in place with Hexal AG, an affiliate within the Sandoz Division of the Novartis Group of Companies (" Sandoz"), for the commercialization of Vitaros(R) in several European countries, including Belgium.
"We are pleased to be working with our partner Sandoz as they make progress towards preparing Vitaros(R) for commercial launch in their licensed territories including Belgium," said Richard Pascoe, Chief Executive Officer of Apricus. "We remain excited about the opportunity for all of our existing partners to bring the first and only on-demand, topical erectile dysfunction treatment to the market this year."
In June 2013, Apricus announced that its marketing application for Vitaros(R) was approved through the European Decentralized Procedure ("DCP"). Under the DCP, Apricus filed its application for marketing approval designating the Netherlands as the Reference Member State ("RMS") on behalf of nine other European Concerned Member States ("CMS") participating in the procedure. The Company continues to work toward obtaining the remaining national phase approvals in Spain and Luxembourg.
Once launched, Vitaros(R) will become the first new and novel ED product in nearly a decade, and with its unique product profile that addresses a large number of patients who cannot or do not respond well to the existing therapies, or who are intolerant to the systemic effects of PDE-5 inhibitors, it is well- positioned for commercial success. In Europe alone, the existing ED products generated over $1 billion in sales in 2012. Apricus believes that a significant portion of the market remains untreated or under-treated, which represents a substantial commercial opportunity for Vitaros(R) .
Vitaros(R) is currently partnered in key markets, including with Takeda in the UK, Sandoz in Germany, Switzerland and certain countries in Northern Europe, Bracco in Italy, Majorelle in France, Monaco and certain African countries, and Abbott in Canada. The Company's existing commercialization partners are preparing for Vitaros(R) product launches in their respective territories with product launches expected throughout 2014.
About Vitaros(R)
Vitaros(R) has been approved for the treatment of ED by the European health authorities and by Health Canada. Vitaros(R) is a topically-applied cream formulation of alprostadil, a vasodilator, combined with our proprietary permeation enhancer DDAIP.HCl, which directly increases blood flow to the penis, causing an erection. Alprostadil is a widely accepted alternative to the PDE-5 inhibitors for difficult to treat patients, and Vitaros(R) , which was determined to be safe and effective by the European health authorities and previously by Health Canada, offers greater market opportunity due to its patient-friendly form versus other alprostadil dosage forms and also relative to oral ED products. With nearly 150 million men worldwide who suffer from ED and an ED market size of approximately $1 billion in revenue in Europe alone, Vitaros(R) represents a major market opportunity for Apricus and its commercial partners given its unique product profile and its potential to treat a large underserved population.
About Apricus Biosciences, Inc.
Apricus Biosciences, Inc. (APRI) is a pharmaceutical company that develops and markets through its licensing partners innovative treatments that have the potential to help large patient populations across numerous, large-market therapeutic classes including male and female sexual health. The Company has one approved product, Vitaros(R) , for the treatment of erectile dysfunction, which is now approved in Europe and Canada and will be commercialized by Apricus' marketing partners, which include Abbott Laboratories Limited, Takeda Pharmaceuticals International GmbH, Hexal AG (Sandoz), Bracco SpA and Laboratoires Majorelle. Femprox(R) , the Company's product candidate for the treatment of female sexual interest/arousal disorder, has successfully completed a nearly 400-subject proof-of-concept study.
For further information on Apricus, visit http://www.apricusbio.com.
Apricus' Forward-Looking Statement Safe Harbor
Statements under the Private Securities Litigation Reform Act, as amended: with the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risks and uncertainties that may individually or mutually impact the matters herein described for a variety of reasons that are outside the control of the Company, including, but not limited to, its ability to further develop its product Vitaros(R) for ED, such as the room temperature version of Vitaros(R) and product candidate Femprox(R) for female sexual interest/arousal disorder among others; to have its product and product candidates receive additional patent protection and be approved by relevant regulatory authorities in Europe, the United States, Canada and in other countries, such as additional national phase approvals for Vitaros(R) in the remaining CMS territories, Spain and Luxembourg; to successfully commercialize such product and product candidates and other NexACT(R) product candidates and drug delivery technology; and to achieve its other development, commercialization and financial goals, such as successfully manufacturing and launching Vitaros(R) in partnered territories. Readers are cautioned not to place undue reliance on these forward-looking statements as actual results could differ materially from the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company's most recent annual report on Form 10-K, as amended, subsequent quarterly reports filed on Form 10-Q, as amended, and other filings made with the SEC. Copies of these reports are available from the SEC's website or without charge from the Company.
CONTACT: Apricus Investor Relations:
David Pitts or Lourdes Catala
Argot Partners
212-600-1902
david@argotpartners.com
lourdes@argotpartners.com
(END) Dow Jones Newswires
01-23-14 1005ET
Copyright 2014, Dow Jones and Company, Inc. News Provided by Acquire Media Corporation
APRI--big news just out-pricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream - Vitaros(R) in Belgium
Vitaros(R) Remains on Track for Launch in 2014
SAN DIEGO, Jan. 23, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (" Apricus" or the "Company") (Nasdaq:APRI) (www.apricusbio.com), today announced that Belgium's Ministry of Social Affairs, Public Health and Environment has granted national phase approval to Vitaros(R) , indicated for the treatment of patients with erectile dysfunction ("ED"). The Company has now received a total of eight national phase approvals for Vitaros(R) , including Belgium, France, Germany, Ireland, Italy, the Netherlands, Sweden and the United Kingdom ("UK") following its broad approval by European health authorities in June 2013. Apricus has an exclusive commercialization partnership in place with Hexal AG, an affiliate within the Sandoz Division of the Novartis Group of Companies (" Sandoz"), for the commercialization of Vitaros(R) in several European countries, including Belgium.
"We are pleased to be working with our partner Sandoz as they make progress towards preparing Vitaros(R) for commercial launch in their licensed territories including Belgium," said Richard Pascoe, Chief Executive Officer of Apricus. "We remain excited about the opportunity for all of our existing partners to bring the first and only on-demand, topical erectile dysfunction treatment to the market this year."
In June 2013, Apricus announced that its marketing application for Vitaros(R) was approved through the European Decentralized Procedure ("DCP"). Under the DCP, Apricus filed its application for marketing approval designating the Netherlands as the Reference Member State ("RMS") on behalf of nine other European Concerned Member States ("CMS") participating in the procedure. The Company continues to work toward obtaining the remaining national phase approvals in Spain and Luxembourg.
Once launched, Vitaros(R) will become the first new and novel ED product in nearly a decade, and with its unique product profile that addresses a large number of patients who cannot or do not respond well to the existing therapies, or who are intolerant to the systemic effects of PDE-5 inhibitors, it is well- positioned for commercial success. In Europe alone, the existing ED products generated over $1 billion in sales in 2012. Apricus believes that a significant portion of the market remains untreated or under-treated, which represents a substantial commercial opportunity for Vitaros(R) .
Vitaros(R) is currently partnered in key markets, including with Takeda in the UK, Sandoz in Germany, Switzerland and certain countries in Northern Europe, Bracco in Italy, Majorelle in France, Monaco and certain African countries, and Abbott in Canada. The Company's existing commercialization partners are preparing for Vitaros(R) product launches in their respective territories with product launches expected throughout 2014.
About Vitaros(R)
Vitaros(R) has been approved for the treatment of ED by the European health authorities and by Health Canada. Vitaros(R) is a topically-applied cream formulation of alprostadil, a vasodilator, combined with our proprietary permeation enhancer DDAIP.HCl, which directly increases blood flow to the penis, causing an erection. Alprostadil is a widely accepted alternative to the PDE-5 inhibitors for difficult to treat patients, and Vitaros(R) , which was determined to be safe and effective by the European health authorities and previously by Health Canada, offers greater market opportunity due to its patient-friendly form versus other alprostadil dosage forms and also relative to oral ED products. With nearly 150 million men worldwide who suffer from ED and an ED market size of approximately $1 billion in revenue in Europe alone, Vitaros(R) represents a major market opportunity for Apricus and its commercial partners given its unique product profile and its potential to treat a large underserved population.
About Apricus Biosciences, Inc.
Apricus Biosciences, Inc. (APRI) is a pharmaceutical company that develops and markets through its licensing partners innovative treatments that have the potential to help large patient populations across numerous, large-market therapeutic classes including male and female sexual health. The Company has one approved product, Vitaros(R) , for the treatment of erectile dysfunction, which is now approved in Europe and Canada and will be commercialized by Apricus' marketing partners, which include Abbott Laboratories Limited, Takeda Pharmaceuticals International GmbH, Hexal AG (Sandoz), Bracco SpA and Laboratoires Majorelle. Femprox(R) , the Company's product candidate for the treatment of female sexual interest/arousal disorder, has successfully completed a nearly 400-subject proof-of-concept study.
For further information on Apricus, visit http://www.apricusbio.com.
Apricus' Forward-Looking Statement Safe Harbor
Statements under the Private Securities Litigation Reform Act, as amended: with the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risks and uncertainties that may individually or mutually impact the matters herein described for a variety of reasons that are outside the control of the Company, including, but not limited to, its ability to further develop its product Vitaros(R) for ED, such as the room temperature version of Vitaros(R) and product candidate Femprox(R) for female sexual interest/arousal disorder among others; to have its product and product candidates receive additional patent protection and be approved by relevant regulatory authorities in Europe, the United States, Canada and in other countries, such as additional national phase approvals for Vitaros(R) in the remaining CMS territories, Spain and Luxembourg; to successfully commercialize such product and product candidates and other NexACT(R) product candidates and drug delivery technology; and to achieve its other development, commercialization and financial goals, such as successfully manufacturing and launching Vitaros(R) in partnered territories. Readers are cautioned not to place undue reliance on these forward-looking statements as actual results could differ materially from the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company's most recent annual report on Form 10-K, as amended, subsequent quarterly reports filed on Form 10-Q, as amended, and other filings made with the SEC. Copies of these reports are available from the SEC's website or without charge from the Company.
CONTACT: Apricus Investor Relations:
David Pitts or Lourdes Catala
Argot Partners
212-600-1902
david@argotpartners.com
lourdes@argotpartners.com
(END) Dow Jones Newswires
01-23-14 1005ET
Copyright 2014, Dow Jones and Company, Inc. News Provided by Acquire Media Corporation
HOV, homebuilder-bought May-7.00 calls at .24---eom
HOV, homebuilder-bought May-7.00 calls at .24---eom
SD-200k buy took out 6.21 through 6.25
SD-200k buy took out 6.21 through 6.25
HELI-breaking out-above 10.00 now-IPO'ed last Friday--eom
HELI-breaking out-above 10.00 now-IPO'ed last Friday--eom
SD--needs to break 6.10--eom
HELI-IPO'ed Friday-break 10.15 and it goes-largest helicopter co. in the world
HELI-IPO'ed Friday-break 10.15 and it goes-largest helicopter co. in the world
SD--over 7.00 short term imho--g/l---eom
RSOL-over 5.00 this week---22 milion float and huge 6.5 million shorts that need to cover after the merger last week
RSOL-over 5.00 this week---22 milion float and huge 6.5 million shorts that need to cover after the merger last week
HELI-IPO'ed Friday at 9.30--read
Company Description
We are the world's largest commercial operator of helicopters based on revenue
of $1.7 billion in fiscal 2013. We are also the world's largest commercial
operator of heavy and medium helicopters based on our fleet of 238 heavy and
medium helicopters as of October 31, 2013. With bases on six
continents, we are
one of only two global commercial helicopter service providers to the offshore
oil and gas industry. Our mission is to provide the highest level of service in
the industry, which we believe will enable our customers to go further, do more
and come home safely. Through our 60 years of experience providing helicopter
services, we believe our brand and reputation have become associated with safe
and reliable transportation and mission-critical logistics solutions. Our fleet
of heavy and medium helicopters, global capabilities and reputation for safety
position us to capitalize on anticipated increases in ultra-deepwater and
deepwater drilling and production spending by our major, national and
independent oil and gas company customers.
Our helicopters are primarily used to facilitate large, long-distance crew
changes on offshore production facilities and drilling rigs. We also provide
search and rescue services, or SAR, and emergency medical services, or EMS, to
government agencies. We maintain a presence in most major offshore oil and gas
markets through a network of approximately 70 bases with operations in
approximately 30 countries, more than any other commercial helicopter service
provider in the world. We cover this expansive and diverse geography with a
technologically advanced fleet of 238 helicopters and the expertise to serve
customers in ultra-deepwater and deepwater locations. To secure and maintain
operating certificates in the many jurisdictions in which we provide helicopter
services, we must meet stringent and diverse regulatory standards across
multiple jurisdictions, and have an established track record in obtaining and
maintaining certificates as well as working with regulators and local partners.
We generate the majority of our oil and gas customer Helicopter Services revenue
from contracts tied to our customers' offshore production operations, which have
long-term transportation requirements. A substantial portion of our remaining
oil and gas customer Helicopter Services revenue comes from transporting
personnel to and from offshore drilling rigs, and we believe this capability
allows us to take advantage of expansion in the global ultra-deepwater rig
fleet. Approximately 71% to 75% of the flying revenue in our Helicopter Services
segment was attributable to fixed monthly charges for the fiscal years ended
April 30, 2011, 2012 and 2013.
We also provide maintenance, repair and overhaul, or MRO, services through our
Heli-One business to both our own Helicopter Services segment and to third-party
customers. Our MRO capabilities enable us to perform heavy structural repairs,
and maintain, overhaul and test helicopters and helicopter components globally
across various helicopter types. We believe our in-house MRO operations through
our Heli-One business enable us to manage our supply chain and maintain our
fleet more efficiently, thereby increasing the availability of our helicopters
and reducing our overall cost of maintenance. In addition, we are the largest
provider of these services (excluding original equipment manufacturers, or
OEMs), which allows us to provide our Heli-One customers with comprehensive MRO
services across multiple helicopter types and families. Our MRO services include
complete maintenance outsourcing solutions, parts sales and distribution,
engineering services, design services and logistics support.
We conduct our business through two operating segments: Helicopter Services for
flying operations and Heli-One for MRO services.
---
CHC Group Ltd., formerly known as FR Horizon Holding (Cayman) Inc., was
incorporated in the Cayman Islands on July 3, 2008 and changed its name by way
of special shareholder resolution dated September 12, 2013 to CHC Group Ltd. CHC
Group Ltd.’s registered office is located at c/o Intertrust Corporate Services
(Cayman) Ltd., 190 Elgin Avenue, George Town, Grand Cayman, KY1-9005, Cayman
Islands.
We have entered into agreements with Heli-One Canada Inc. and Heli-One American
Support, LLC to provide certain management services, subject to authority limits
as determined by our board of directors and set out in such agreements. The
corporate headquarters of Heli-One Canada Inc.’s offices is located at 4740
Agar Drive, Richmond, British Columbia, V7B 1A3 Canada and its telephone number
is (604) 276-7500. Our website is located at www.chc.ca.
Read more: http://www.nasdaq.com/markets/ipos/company/chc-group-ltd-915961-73530#ixzz2qzJ4N8EU
HELI-IPO'ed Friday at 9.30--read
Company Description
We are the world's largest commercial operator of helicopters based on revenue
of $1.7 billion in fiscal 2013. We are also the world's largest commercial
operator of heavy and medium helicopters based on our fleet of 238 heavy and
medium helicopters as of October 31, 2013. With bases on six
continents, we are
one of only two global commercial helicopter service providers to the offshore
oil and gas industry. Our mission is to provide the highest level of service in
the industry, which we believe will enable our customers to go further, do more
and come home safely. Through our 60 years of experience providing helicopter
services, we believe our brand and reputation have become associated with safe
and reliable transportation and mission-critical logistics solutions. Our fleet
of heavy and medium helicopters, global capabilities and reputation for safety
position us to capitalize on anticipated increases in ultra-deepwater and
deepwater drilling and production spending by our major, national and
independent oil and gas company customers.
Our helicopters are primarily used to facilitate large, long-distance crew
changes on offshore production facilities and drilling rigs. We also provide
search and rescue services, or SAR, and emergency medical services, or EMS, to
government agencies. We maintain a presence in most major offshore oil and gas
markets through a network of approximately 70 bases with operations in
approximately 30 countries, more than any other commercial helicopter service
provider in the world. We cover this expansive and diverse geography with a
technologically advanced fleet of 238 helicopters and the expertise to serve
customers in ultra-deepwater and deepwater locations. To secure and maintain
operating certificates in the many jurisdictions in which we provide helicopter
services, we must meet stringent and diverse regulatory standards across
multiple jurisdictions, and have an established track record in obtaining and
maintaining certificates as well as working with regulators and local partners.
We generate the majority of our oil and gas customer Helicopter Services revenue
from contracts tied to our customers' offshore production operations, which have
long-term transportation requirements. A substantial portion of our remaining
oil and gas customer Helicopter Services revenue comes from transporting
personnel to and from offshore drilling rigs, and we believe this capability
allows us to take advantage of expansion in the global ultra-deepwater rig
fleet. Approximately 71% to 75% of the flying revenue in our Helicopter Services
segment was attributable to fixed monthly charges for the fiscal years ended
April 30, 2011, 2012 and 2013.
We also provide maintenance, repair and overhaul, or MRO, services through our
Heli-One business to both our own Helicopter Services segment and to third-party
customers. Our MRO capabilities enable us to perform heavy structural repairs,
and maintain, overhaul and test helicopters and helicopter components globally
across various helicopter types. We believe our in-house MRO operations through
our Heli-One business enable us to manage our supply chain and maintain our
fleet more efficiently, thereby increasing the availability of our helicopters
and reducing our overall cost of maintenance. In addition, we are the largest
provider of these services (excluding original equipment manufacturers, or
OEMs), which allows us to provide our Heli-One customers with comprehensive MRO
services across multiple helicopter types and families. Our MRO services include
complete maintenance outsourcing solutions, parts sales and distribution,
engineering services, design services and logistics support.
We conduct our business through two operating segments: Helicopter Services for
flying operations and Heli-One for MRO services.
---
CHC Group Ltd., formerly known as FR Horizon Holding (Cayman) Inc., was
incorporated in the Cayman Islands on July 3, 2008 and changed its name by way
of special shareholder resolution dated September 12, 2013 to CHC Group Ltd. CHC
Group Ltd.’s registered office is located at c/o Intertrust Corporate Services
(Cayman) Ltd., 190 Elgin Avenue, George Town, Grand Cayman, KY1-9005, Cayman
Islands.
We have entered into agreements with Heli-One Canada Inc. and Heli-One American
Support, LLC to provide certain management services, subject to authority limits
as determined by our board of directors and set out in such agreements. The
corporate headquarters of Heli-One Canada Inc.’s offices is located at 4740
Agar Drive, Richmond, British Columbia, V7B 1A3 Canada and its telephone number
is (604) 276-7500. Our website is located at www.chc.ca.
Read more: http://www.nasdaq.com/markets/ipos/company/chc-group-ltd-915961-73530#ixzz2qzJ4N8EU
HELI at 9.75-full description of the IPO today-We are the world's largest commercial operator of helicopters based on revenue
of $1.7 billion in fiscal 2013. We are also the world's largest commercial
operator of heavy and medium helicopters based on our fleet of 238 heavy and
medium helicopters as of October 31, 2013. With bases on six
continents, we are
one of only two global commercial helicopter service providers to the offshore
oil and gas industry. Our mission is to provide the highest level of service in
the industry, which we believe will enable our customers to go further, do more
and come home safely. Through our 60 years of experience providing helicopter
services, we believe our brand and reputation have become associated with safe
and reliable transportation and mission-critical logistics solutions. Our fleet
of heavy and medium helicopters, global capabilities and reputation for safety
position us to capitalize on anticipated increases in ultra-deepwater and
deepwater drilling and production spending by our major, national and
independent oil and gas company customers.
Our helicopters are primarily used to facilitate large, long-distance crew
changes on offshore production facilities and drilling rigs. We also provide
search and rescue services, or SAR, and emergency medical services, or EMS, to
government agencies. We maintain a presence in most major offshore oil and gas
markets through a network of approximately 70 bases with operations in
approximately 30 countries, more than any other commercial helicopter service
provider in the world. We cover this expansive and diverse geography with a
technologically advanced fleet of 238 helicopters and the expertise to serve
customers in ultra-deepwater and deepwater locations. To secure and maintain
operating certificates in the many jurisdictions in which we provide helicopter
services, we must meet stringent and diverse regulatory standards across
multiple jurisdictions, and have an established track record in obtaining and
maintaining certificates as well as working with regulators and local partners.
We generate the majority of our oil and gas customer Helicopter Services revenue
from contracts tied to our customers' offshore production operations, which have
long-term transportation requirements. A substantial portion of our remaining
oil and gas customer Helicopter Services revenue comes from transporting
personnel to and from offshore drilling rigs, and we believe this capability
allows us to take advantage of expansion in the global ultra-deepwater rig
fleet. Approximately 71% to 75% of the flying revenue in our Helicopter Services
segment was attributable to fixed monthly charges for the fiscal years ended
April 30, 2011, 2012 and 2013.
We also provide maintenance, repair and overhaul, or MRO, services through our
Heli-One business to both our own Helicopter Services segment and to third-party
customers. Our MRO capabilities enable us to perform heavy structural repairs,
and maintain, overhaul and test helicopters and helicopter components globally
across various helicopter types. We believe our in-house MRO operations through
our Heli-One business enable us to manage our supply chain and maintain our
fleet more efficiently, thereby increasing the availability of our helicopters
and reducing our overall cost of maintenance. In addition, we are the largest
provider of these services (excluding original equipment manufacturers, or
OEMs), which allows us to provide our Heli-One customers with comprehensive MRO
services across multiple helicopter types and families. Our MRO services include
complete maintenance outsourcing solutions, parts sales and distribution,
engineering services, design services and logistics support.
We conduct our business through two operating segments: Helicopter Services for
flying operations and Heli-One for MRO services.
---
CHC Group Ltd., formerly known as FR Horizon Holding (Cayman) Inc., was
incorporated in the Cayman Islands on July 3, 2008 and changed its name by way
of special shareholder resolution dated September 12, 2013 to CHC Group Ltd. CHC
Group Ltd.’s registered office is located at c/o Intertrust Corporate Services
(Cayman) Ltd., 190 Elgin Avenue, George Town, Grand Cayman, KY1-9005, Cayman
Islands.
We have entered into agreements with Heli-One Canada Inc. and Heli-One American
Support, LLC to provide certain management services, subject to authority limits
as determined by our board of directors and set out in such agreements. The
corporate headquarters of Heli-One Canada Inc.’s offices is located at 4740
Agar Drive, Richmond, British Columbia, V7B 1A3 Canada and its telephone number
is (604) 276-7500. Our website is located at www.chc.ca.
Read more: http://www.nasdaq.com/markets/ipos/company/chc-group-ltd-915961-73530#ixzz2qgeAhoIQ
thanks!! eom
HELI-undervalued IPO today at 9.72-We are the world's largest commercial operator of helicopters based on revenue
of $1.7 billion in fiscal 2013. We are also the world's largest commercial
operator of heavy and medium helicopters based on our fleet of 238 heavy and
medium helicopters as of October 31, 2013. With bases on six
continents, we are
one of only two global commercial helicopter service providers to the offshore
oil and gas industry. Our mission is to provide the highest level of service in
the industry, which we believe will enable our customers to go further, do more
and come home safely. Through our 60 years of experience providing helicopter
services, we believe our brand and reputation have become associated with safe
and reliable transportation and mission-critical logistics solutions. Our fleet
of heavy and medium helicopters, global capabilities and reputation for safety
position us to capitalize on anticipated increases in ultra-deepwater and
deepwater drilling and production spending by our major, national and
independent oil and gas company customers.
Our helicopters are primarily used to facilitate large, long-distance crew
changes on offshore production facilities and drilling rigs. We also provide
search and rescue services, or SAR, and emergency medical services, or EMS, to
government agencies. We maintain a presence in most major offshore oil and gas
markets through a network of approximately 70 bases with operations in
approximately 30 countries, more than any other commercial helicopter service
provider in the world. We cover this expansive and diverse geography with a
technologically advanced fleet of 238 helicopters and the expertise to serve
customers in ultra-deepwater and deepwater locations. To secure and maintain
operating certificates in the many jurisdictions in which we provide helicopter
services, we must meet stringent and diverse regulatory standards across
multiple jurisdictions, and have an established track record in obtaining and
maintaining certificates as well as working with regulators and local partners.
We generate the majority of our oil and gas customer Helicopter Services revenue
from contracts tied to our customers' offshore production operations, which have
long-term transportation requirements. A substantial portion of our remaining
oil and gas customer Helicopter Services revenue comes from transporting
personnel to and from offshore drilling rigs, and we believe this capability
allows us to take advantage of expansion in the global ultra-deepwater rig
fleet. Approximately 71% to 75% of the flying revenue in our Helicopter Services
segment was attributable to fixed monthly charges for the fiscal years ended
April 30, 2011, 2012 and 2013.
We also provide maintenance, repair and overhaul, or MRO, services through our
Heli-One business to both our own Helicopter Services segment and to third-party
customers. Our MRO capabilities enable us to perform heavy structural repairs,
and maintain, overhaul and test helicopters and helicopter components globally
across various helicopter types. We believe our in-house MRO operations through
our Heli-One business enable us to manage our supply chain and maintain our
fleet more efficiently, thereby increasing the availability of our helicopters
and reducing our overall cost of maintenance. In addition, we are the largest
provider of these services (excluding original equipment manufacturers, or
OEMs), which allows us to provide our Heli-One customers with comprehensive MRO
services across multiple helicopter types and families. Our MRO services include
complete maintenance outsourcing solutions, parts sales and distribution,
engineering services, design services and logistics support.
We conduct our business through two operating segments: Helicopter Services for
flying operations and Heli-One for MRO services.
---
CHC Group Ltd., formerly known as FR Horizon Holding (Cayman) Inc., was
incorporated in the Cayman Islands on July 3, 2008 and changed its name by way
of special shareholder resolution dated September 12, 2013 to CHC Group Ltd. CHC
Group Ltd.’s registered office is located at c/o Intertrust Corporate Services
(Cayman) Ltd., 190 Elgin Avenue, George Town, Grand Cayman, KY1-9005, Cayman
Islands.
We have entered into agreements with Heli-One Canada Inc. and Heli-One American
Support, LLC to provide certain management services, subject to authority limits
as determined by our board of directors and set out in such agreements. The
corporate headquarters of Heli-One Canada Inc.’s offices is located at 4740
Agar Drive, Richmond, British Columbia, V7B 1A3 Canada and its telephone number
is (604) 276-7500. Our website is located at www.chc.ca.
Read more: http://www.nasdaq.com/markets/ipos/company/chc-group-ltd-915961-73530#ixzz2qgeAhoIQ
SD-bought June 7.00 calls at .31---dd it--g/l
SD-bought June 7.00 calls at .31---dd it--g/l
RSOL--more action on 5.00 calls on the merger this week--eom
RSOL--more action on 5.00 calls on the merger this week--eom
RSOL--more action on 5.00 calls on the merger this week--eom
RSOL--more action on 5.00 calls on the merger this week--eom
HELI--new IPO today-in at 9.34---eom
HELI--new IPO today--eom
HELI--new IPO today--Company Description
We are the world's largest commercial operator of helicopters based on revenue
of $1.7 billion in fiscal 2013. We are also the world's largest commercial
operator of heavy and medium helicopters based on our fleet of 238 heavy and
medium helicopters as of October 31, 2013. With bases on six
HELI--new IPO today--Company Description
We are the world's largest commercial operator of helicopters based on revenue
of $1.7 billion in fiscal 2013. We are also the world's largest commercial
operator of heavy and medium helicopters based on our fleet of 238 heavy and
medium helicopters as of October 31, 2013. With bases on six
HELI--new IPO today--Company Description
We are the world's largest commercial operator of helicopters based on revenue
of $1.7 billion in fiscal 2013. We are also the world's largest commercial
operator of heavy and medium helicopters based on our fleet of 238 heavy and
medium helicopters as of October 31, 2013. With bases on six
GSI-at 1.01-china steel--2.6 bil. revenue-just 55 mil. market cap--way undervalued imho
GSI-at 1.01-china steel--2.6 bil. revenue-just 55 mil. market cap--way undervalued imho
GSI-been watching someone accumulate .90 and up for 2 weeks-/ I jumped in yesterday when a 25k bid poped up at 1.00--radar close--China steel company
GSI-been watching someone accumulate .90 and up for 2 weeks-/ I jumped in yesterday when a 25k bid poped up at 1.00--radar close--China steel company
GSI at 1.01-CHINA steel co. nice chart- http://stockcharts.com/h-sc/ui?s=GSI&p=D&b=5&g=0&id=p50077495739
GSI at 1.01-CHINA steel co. nice chart- http://stockcharts.com/h-sc/ui?s=GSI&p=D&b=5&g=0&id=p50077495739
GSI at 1.01-CHINA steel co. nice chart- http://stockcharts.com/h-sc/ui?s=GSI&p=D&b=5&g=0&id=p50077495739
nice chart--thanks---eom